Although the PCT cutoff of 0.5 ng/mL is commonly used, as a single point, it is not specific enough to determine bacterial co-infection in the setting of either COVID-19 or influenza, as the data demonstrate a high proportion of patients will have a procalcitonin above this level during their course of disease with either virus. Here, CALCA is linked to influenza.